Mark John Austin - 17 Jul 2024 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Reporting relationship: VP Finance/Prin Fin&Acct Offic
Issuer ticker: CATX
Reported as of: 17 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Jul 2024, 07:36:52 UTC
Prior SEC filing: 24 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Austin

Key filing fact

Mark John Austin filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 19 Jul 2024.

Key facts

This page summarizes Mark John Austin's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 19 Jul 2024, 07:36.

Change

Previous filing in this sequence was filed on 24 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CATX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +34,500
Change %
Price: $0.000000
Shares after: 34,500
Date: 17 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,500
Exercise price: $11.96
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (07/17/2024), subject to a continued service relationship.